Product Launch (Blog)

Sep, 14 2023

Egg Allergy Unveiled: Diagnosis, Treatment, and Emerging Trends in Managing Allergic Reactions

Egg allergy management revolves around applications such as precise diagnosis through skin prick tests and blood tests to detect allergen-specific antibodies. Key features of the egg allergy market include allergen avoidance by scrutinizing food labels, seeking egg substitutes in recipes, and carrying epinephrine auto-injectors for emergency treatment. This condition's use lies in raising awareness among individuals, schools, restaurants, and food manufacturers about the presence of egg allergens to prevent accidental exposure and facilitate safe dining and food choices for those with egg allergies.

According to Data Bridge Market Research, the Global Egg Allergy Market is expected to reach USD 3,491.88 million in 2029. The market is expected to grow with a CAGR of 7.22% in the forecast period of 2022 to 2029.

“Increasing prevalence of asthma boosts the market’s growth”

The increasing prevalence of asthma is driving the growth of the egg allergy market. Asthma and egg allergy often co-occur, as eggs can trigger asthma symptoms in allergic individuals. This heightened awareness of the connection between the two conditions prompts more comprehensive allergy testing and diagnosis, leading to a larger pool of identified egg allergy patients. As a result, there is a growing demand for specialized egg-free products and treatments, propelling the expansion of the egg allergy market to cater to these needs.

What restraints the growth of the global egg allergy market?

“Lack of awareness among the general population and healthcare providers restraints the market’s growth”

The egg allergy market faces growth constraints due to a lack of awareness among the general population and healthcare providers. Many individuals with egg allergies go undiagnosed or receive delayed diagnoses because symptoms can be subtle or mistaken for other conditions. This hinders the market's growth by limiting the identification of egg allergy cases and delaying the adoption of allergen-free products and treatments. Increasing awareness through educational campaigns and improved medical training is essential to address this constraint and support market expansion.

Segmentation: Global Egg Allergy Market

The global egg allergy market is segmented on the basis of diagnosis, treatment, and end-users. 

  • On the basis of diagnosis, the egg allergy market is segmented into blood test, skin-prick test, atopy patch test, oral food challenge, and others.
  • On the basis of treatment, the egg allergy market is segmented into oral immunotherapy, medication, others.
  • On the basis of the end-users, the egg allergy market is segmented into hospital and clinics, diagnostic centers, research and academic institutes, and others.

Regional Insights: Europe dominates the Global Egg Allergy Market

Europe dominates the egg allergy market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period due to government initiatives and the presence of major companies specializing in egg allergy-related products. These combined efforts foster research, development, and accessibility to treatments, catering to the needs of individuals with egg allergies and propelling market expansion in the region.

Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to its vast potential audience within regions with large populations, unexplored market opportunities, and supportive government policies. These factors collectively encourage market expansion, as they enable increased awareness, accessibility, and research efforts in the field of egg allergy diagnosis and treatment.

To know more about the study visit, https://www.databridgemarketresearch.com/fr/reports/global-egg-allergy-market

The Prominent Key Players Operating in the Global Egg Allergy Market Include:

  • Genentech, Inc. (U.S.)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Bayer AG (Germany)
  • Abbott (U.S.)
  • Astellas Pharma Inc. (Japan)
  • Sanofi (France)
  • Merck & Co., Inc. (U.S.)
  • Creative Diagnostic Medicare Pvt. Ltd. (India)
  • IMMUNE TECHNOLOGY Corp (Taiwan)

Above are the key players covered in the report, to know about more and exhaustive list of global egg allergy market companies contact, https://www.databridgemarketresearch.com/fr/contact

Research Methodology: Global Egg Allergy Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.


Client Testimonials